You are here

Article Text

Article menu
Download PDFPDF
Editorial
“Heavy oil” for intraocular tamponade in retinal detachment surgery
  1. R B Bhisitkul1,
  2. V H Gonzalez2
  1. 1UCSF Beckman Vision Center, 10 Koret Way, K301, San Francisco, CA 94143, USA
  2. 2Valley Retina Institute, 1309 E Ridge Road, McAllen, TX 78503, USA
  1. Correspondence to: Robert Bhisitkul MD, PhD, UCSF Beckman Vision Center, 10 Koret Way, K301, San Francisco, CA 94143, USA; bhisititsa.ucsf.edu

https://doi.org/10.1136/bjo.2004.057182

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Thicker than water

    In this issue of BJO (p 662) Wong and colleagues present data from a prospective pilot study on the use of a long acting, heavier than water internal tamponade agent, Densiron-68, for retinal detachment (RD) repair. Some time ago1 we drew up a retinal surgeon’s wish list of vitreoretinal agents and adjuncts that are currently sorely lacking in surgical technology, including enzymatic vitreolysis, and antifibroproliferative drugs. Looming large on that wish list was a long acting heavier than water tamponade agent. Long coveted by vitrectomy surgeons, extended tamponade with heavy liquids would at last allow us to address the well recognised limitations of current tamponade agents, limitations that are for the most part imposed by gravity. Now, long acting inferior tamponade with “heavy oil” may soon be at hand, as described in this article.

    The era of intraocular tamponade was ushered in with the …

    View Full Text

    Linked Articles